VNRX insider buying
2 cluster buysVOLITIONRX LTD · Healthcare
When two or more insiders at VOLITIONRX LTD buy VNRX on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in VNRX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Mar 26 – Nov 17, 2025Detected Nov 17, 2025High conviction4 insidersTotal bought$495.0KMarket cap$11.3M
- Dec 9 – Dec 9, 2024Detected Dec 9, 2024High conviction4 insidersTotal bought$254.0KMarket cap$11.3M
All notable open-market buys in VNRX
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Nov 17, 2025 | Reynolds Cameron Johncluster Director, President and CEO | 20,000 | $0.35 | $7.0K | SEC ↗ |
| Oct 14, 2025 | Reynolds Cameron Johncluster Director, President and CEO | 110,000 | $0.51 | $56.1K | SEC ↗ |
| Oct 14, 2025 | Innes Guy Archibaldcluster Director | 96,153 | $0.51 | $49.0K | SEC ↗ |
| Oct 14, 2025 | STILL TIMOTHY Icluster Director | 48,076 | $0.51 | $24.5K | SEC ↗ |
| Sep 12, 2025 | Reynolds Cameron Johncluster Director, President and CEO | 15,000 | $0.66 | $9.9K | SEC ↗ |
| Aug 5, 2025 | Reynolds Cameron Johncluster Director, President and CEO | 78,125 | $0.64 | $50.0K | SEC ↗ |
| Aug 5, 2025 | Innes Guy Archibaldcluster Director | 78,125 | $0.64 | $50.0K | SEC ↗ |
| Jun 12, 2025 | Reynolds Cameron Johncluster Director, President and CEO | 12,500 | $0.59 | $7.4K | SEC ↗ |
| Jun 3, 2025 | Innes Guy Archibaldcluster Director | 20,000 | $0.54 | $10.8K | SEC ↗ |
| May 19, 2025 | Micallef Jacob Vincentcluster Chief Scientific Officer | 50,000 | $0.43 | $21.5K | SEC ↗ |
| May 19, 2025 | Reynolds Cameron Johncluster Director, President and CEO | 20,000 | $0.44 | $8.8K | SEC ↗ |
| Mar 26, 2025 | Reynolds Cameron Johncluster Director, President and CEO | 181,818 | $0.55 | $100.0K | SEC ↗ |
| Mar 26, 2025 | Innes Guy Archibaldcluster Director | 181,818 | $0.55 | $100.0K | SEC ↗ |
| Dec 9, 2024 | Innes Guy Archibaldcluster Director | 174,764 | $0.57 | $99.6K | SEC ↗ |
| Dec 9, 2024 | Reynolds Cameron Johncluster Director, President and CEO | 139,811 | $0.57 | $79.7K | SEC ↗ |
| Dec 9, 2024 | STILL TIMOTHY Icluster Director | 87,382 | $0.57 | $49.8K | SEC ↗ |
| Dec 9, 2024 | Micallef Jacob Vincentcluster Chief Scientific Officer | 43,691 | $0.57 | $24.9K | SEC ↗ |
| Aug 20, 2024 | Director | 150,000 | $0.67 | $100.5K | SEC ↗ |
More Healthcare stocks with insider cluster buys
VNRX insider buying — FAQ
- Are insiders buying VNRX stock?
- Yes — 5 distinct insiders have bought VNRX (VOLITIONRX LTD) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Nov 17, 2025.
- How much VNRX stock have insiders bought?
- Insiders have bought a combined $849.6K of VNRX across 18 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in VNRX?
- A cluster buy is two or more distinct VOLITIONRX LTD insiders — officers, directors, or 10% owners — each buying VNRX on the open market within a rolling window. VNRX has 2 detected cluster buys to date.
- Where does this VNRX insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in VNRX
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy VNRX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding VNRX.